The company, Parenchyma Biotech, focuses on the development of immunotherapy drugs for the treatment of autoimmune diseases and cancer. With expertise in immunology, they are dedicated to creating innovative solutions that harness the power of the immune system to combat these conditions. By developing new drugs, they aim to provide effective and targeted treatments that can improve the lives of patients suffering from these diseases.